Rakuten Medical completes $119 million Series E financing to develop Alluminox™ platform.
Amount Raised
$119 Million
Round Type
Series E
San MateoBiotechnologyInvestors
Description
Rakuten Medical, Inc. completed a $119 million Series E financing, including $45 million in new capital and the conversion of $74 million of convertible promissory notes with accrued interest. The funding will support photoimmunotherapy clinical trials, drug discovery, and medical device development for the proprietary Alluminox™ platform.
Quick answer
Aspyrian Therapeutics, Inc. raised $119 Million in a Series E round, dated March 6, 2024. Investors: Dai Ichi Life Insurance Company, Limited, Mizuho Bank, Ltd., SBI Group, Rakuten Group and Hikma Pharmaceuticals PLC. Aspyrian Therapeutics, Inc. is based in San Mateo, California, United States.
- How much did Aspyrian Therapeutics, Inc. raise?
- Aspyrian Therapeutics, Inc. raised $119 Million in a Series E round on March 6, 2024.
- Who invested in Aspyrian Therapeutics, Inc?
- Dai Ichi Life Insurance Company, Limited, Mizuho Bank, Ltd., SBI Group, Rakuten Group and Hikma Pharmaceuticals PLC are named as investors in this round.
- What does Aspyrian Therapeutics, Inc. do?
- Aspyrian Therapeutics is developing a first-in-class cancer treatment utilizing photoimmunotherapy.
- Where is Aspyrian Therapeutics, Inc. based and how big is it?
- Aspyrian Therapeutics, Inc. is based in San Mateo, California, United States.
- Who are the decision-makers at Aspyrian Therapeutics, Inc?
- Fundz holds 2 contacts at Aspyrian Therapeutics, Inc., including the Vice President Finance Accounting. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Aspyrian Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Diagnostic Support Services raised $660K (Seed) on April 19, 2024.
- Corner Therapeutics raised $54M (Series A) on April 19, 2024.
- Curio Legacy Ventures raised $14M (Seed) on April 19, 2024.
- Pathios Therapeutics raised $25M (Series B) on April 19, 2024.
- Outrun Therapeutics raised $10M (Seed) on April 18, 2024.
- OMEAT raised $37M (Series A) on April 18, 2024.
Who to call at Aspyrian Therapeutics, Inc., and when
A new round usually means Aspyrian Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aspyrian Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aspyrian Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aspyrian Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aspyrian Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aspyrian Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.